Bio B2B 〉 Selective Search Results
Your Selection Setting ：CMO；
Selective Search Results :
Biotech Companies 8 record(s)；
Orient Pharma Co., Ltd.
Orient Pharma (OP) was established on Feb 1, 2008. It is focusing on the development and manufactureing of 505(b)(2) new drugs. There are more than 170 employee and 35% are dedicated to R&D. 70% of the employee own master or PhD degrees. Located in Yunlin county in the central of Taiwan, the Yunlin plant obtained the approval for PIC/S GMP from the Taiwan FDA
Vita Genomics, Inc.
The Leading Pharmacogenomics Company in Asia PacificVita Genomics, founded in March 2001, has established its headquarters and main facility in Taipei, Taiwan since January 2002. The mission of Vita Genomics is to study and understand what affects the Asian population in order to better diagnose, treat, and eventually cure diseases. Currently, in order to provide clinical and omics services to clinical
Nang Kuang Pharmaceutical Co., Ltd.
Nang Kuang, founded in 1963, is a leading parenteral pharmaceutical company in Taiwan. The facility has passed US FDA and Japan PMDA inspections. Our major products including anticancer injections (isolator system), large volume parenterals ( LVP; PP-soft bag), aseptic parenterals (Ampoule、Vial), lyophilized injection, aseptic Pre-filled syringe、Pre-mixed IV infusion
ScinoPharm Taiwan, Ltd.
Founded in 1997, with initial on-site operations beginning in November 1999, ScinoPharm offers a wide array of process R&D services and API manufacturing capabilities designed to satisfy customers' exact requirements and facilitate their rapid market introductions. ScinoPharm specializes in process R&D and the production of CGMP Active Pharmaceutical Ingredients (APIs).ScinoPharm targets
SCI Pharmtech, Inc.
SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.Since 1989, SCI has satisfied worldwide customers with quality and cost-effective APIs, advanced intermediates, and customproducts.Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effectiveproduction
EirGenix is a Biologic Drug Development Company, and a Contract Development and Manufacturing Organization (CDMO). Current pipelines involve seven products in development ranging from discovery to clinical, such as HER2 family biosimilars, antibody-drug conjugates (ADCs), and carrier protein for vaccine therapy.EirGenix provides high quality and cost-effective service, supporting our clients
Bora Pharmaceuticals Co., Ltd.
IntroductionBora Pharmaceutical is one of the premier pharmaceutical companies in Taiwan that covers the entire pharmaceutical supply chain from research and development all the way to sales and distribution. We provide pharmaceutical CDMO and CMO services for Taiwan domestic and global pharmaceutical companies around the world.Bora is USFDA, MHRA, and PIC/S certified, and we produce pharmaceuticals
JHL Biotech, Inc.
JHL Biotech is a biopharmaceutical company that develops biosimilars and accelerates the development programs of distinguished clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development to commercial manufacturing with both global and regional regulatory affairs expertise.Founded in 2012